valdecoxib has been researched along with Rheumatoid Arthritis in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 22 (91.67) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atukorala, I; Hunter, DJ | 1 |
| Bartzatt, R | 1 |
| Bensen, W; Espinoza, L; Paperiello, B; Recker, DP; Riley, W; Weaver, A; Zhao, WW | 1 |
| Baker, DE | 1 |
| Alsalameh, S; Burian, M; Geisslinger, G; Mahr, G; Woodcock, BG | 1 |
| Pavelka, K; Recker, DP; Verburg, KM | 1 |
| Goldstein, JL; Kent, JD; Kivitz, AJ; Palmer, RC; Recker, DP; Verburg, KM | 1 |
| Chavez, ML; DeKorte, CJ | 1 |
| Niculescu, L; Peña, B; von Scheele, B; Wong, J | 1 |
| Burian, M; Geisslinger, G | 1 |
| Fenton, C; Keating, GM; Wagstaff, AJ | 1 |
| Malaise, M; Scheen, AJ | 1 |
| Boggie, DT; Delattre, ML; Morreale, AP; Plowman, BK; Schaefer, MG; Tran, F | 1 |
| Agrawal, N; Eisen, GM; Goldstein, JL; Kent, JD; Stenson, WF; Verburg, KM | 1 |
| Edwards, JE; McQuay, HJ; Moore, AR | 1 |
| Kellner, H | 1 |
| Jaeger, C; Jappe, U | 1 |
| Eisen, GM; Goldstein, JL; Hanna, DB; Rublee, DA | 1 |
| Goldstein, JL; Mayne, TJ; Rabeneck, L; Rublee, DA; Vu, A | 1 |
| Hochberg, MC | 1 |
| Brown, MT; Kivitz, AJ; Verburg, KM; Williams, GW | 1 |
| Berger, M; Fiechtner, J; Gibofsky, A; Pan, S; Rodrigues, J | 1 |
11 review(s) available for valdecoxib and Rheumatoid Arthritis
| Article | Year |
|---|---|
Valdecoxib : the rise and fall of a COX-2 inhibitor.
Topics: Animals; Arthritis, Rheumatoid; Cyclooxygenase 2 Inhibitors; Humans; Isoxazoles; Osteoarthritis; Sulfonamides; Treatment Outcome | 2013 |
Valdecoxib.
Topics: Arthritis, Rheumatoid; Cyclooxygenase 2; Enzyme Inhibitors; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 2002 |
Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Availability; Bone Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; Female; Humans; Isoenzymes; Isoxazoles; Liver Diseases; Male; Membrane Proteins; Middle Aged; Mouth Diseases; Osteoarthritis; Pain; Prostaglandin-Endoperoxide Synthases; Rats; Sulfonamides | 2003 |
Valdecoxib: a review.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Dysmenorrhea; Enzyme Inhibitors; Female; Humans; Isoxazoles; Male; Osteoarthritis; Pain, Postoperative; Sulfonamides; Treatment Outcome | 2003 |
[Clinical pharmacology of the selective COX-2 inhibitors].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Clinical Trials, Phase III as Topic; Cyclooxygenase Inhibitors; Diclofenac; Humans; Isoxazoles; Lactones; Naproxen; Osteoarthritis; Pain; Pain, Postoperative; Placebos; Pyrazoles; Sulfonamides; Sulfones | 2003 |
Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
Topics: Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; Female; Half-Life; Humans; Intestinal Absorption; Isoxazoles; Male; Osteoarthritis; Pain, Postoperative; Randomized Controlled Trials as Topic; Sulfonamides; Tissue Distribution; Treatment Outcome | 2004 |
[Valdecoxib (Bextra)].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Dysmenorrhea; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Isoxazoles; Osteoarthritis; Pain, Postoperative; Prodrugs; Sulfonamides | 2004 |
Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Multicenter Studies as Topic; Osteoarthritis; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfonamides | 2004 |
Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
Topics: Arthritis, Rheumatoid; Humans; Isoxazoles; Osteoarthritis; Randomized Controlled Trials as Topic; Sulfonamides | 2004 |
Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Dyspepsia; Female; Humans; Isoxazoles; Male; Middle Aged; Nausea; Osteoarthritis; Randomized Controlled Trials as Topic; Sulfonamides | 2005 |
COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Etoricoxib; Humans; Isoxazoles; Lactones; Membrane Proteins; Organic Chemicals; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyridines; Randomized Controlled Trials as Topic; Rheumatology; Sulfonamides; Sulfones; Treatment Outcome | 2005 |
8 trial(s) available for valdecoxib and Rheumatoid Arthritis
| Article | Year |
|---|---|
Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: a randomized, controlled comparison with placebo and naproxen.
Topics: Administration, Oral; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Health Status; Humans; Isoxazoles; Joints; Male; Middle Aged; Naproxen; Pain Measurement; Self-Examination; Severity of Illness Index; Sulfonamides; Treatment Outcome | 2002 |
Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Humans; Isoenzymes; Isoxazoles; Male; Membrane Proteins; Middle Aged; Pain Measurement; Peptic Ulcer; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Treatment Outcome | 2003 |
A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Isoxazoles; Naproxen; Osteoarthritis; Pain; Risk Factors; Sulfonamides | 2003 |
Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Diclofenac; Drug Costs; Female; Health Resources; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Peptic Ulcer; Sulfonamides | 2003 |
Therapeutic interchange involving replacement of rofecoxib or celecoxib with valdecoxib.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Celecoxib; Chronic Disease; Cost Savings; Cyclooxygenase 2; Drug Utilization Review; Endpoint Determination; Female; Hospitals, Veterans; Humans; Isoenzymes; Isoxazoles; Lactones; Male; Membrane Proteins; Osteoarthritis; Pain; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Therapeutic Equivalency | 2004 |
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Dyspepsia; Female; Humans; Ibuprofen; Isoxazoles; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Patient Satisfaction; Placebos; Quality of Life; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract | 2005 |
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Naproxen; Sulfonamides; Treatment Outcome | 2006 |
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Topics: Activities of Daily Living; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Naproxen; Pain Measurement; Patient Satisfaction; Placebos; Severity of Illness Index; Sulfonamides; Time Factors; Treatment Outcome | 2007 |
5 other study(ies) available for valdecoxib and Rheumatoid Arthritis
| Article | Year |
|---|---|
Drug analogs of COX-2 selective inhibitors lumiracoxib and valdecoxib derived from in silico search and optimization.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Computer Simulation; Cyclooxygenase 2 Inhibitors; Diclofenac; Drug Design; Humans; Isoxazoles; Models, Molecular; Neoplasms; Pain; Sulfonamides | 2014 |
[Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Cost Savings; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Germany; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; National Health Programs; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 2003 |
[Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Costs; Germany; Humans; Isoxazoles; Osteoarthritis; Peptic Ulcer; Product Surveillance, Postmarketing; Risk Factors; Sulfonamides | 2004 |
Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dermatitis, Allergic Contact; Drug Eruptions; Exanthema; Humans; Isoxazoles; Male; Patch Tests; Sulfonamides | 2005 |
Valdecoxib (Bextra)--a new cox-2 inhibitor.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoxazoles; Kidney Diseases; Osteoarthritis; Peptic Ulcer; Sulfonamides | 2002 |